Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
Ticker SymbolSRTS
Company nameSensus Healthcare Inc
IPO dateJun 03, 2016
CEOMr. Joseph C. Sardano
Number of employees35
Security typeOrdinary Share
Fiscal year-endJun 03
Address851 Broken Sound Pkwy NW Ste 215
CityBOCA RATON
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code33487-3635
Phone15619225808
Websitehttps://sensushealthcare.com/
Ticker SymbolSRTS
IPO dateJun 03, 2016
CEOMr. Joseph C. Sardano
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data